IL17A and rheumatoid arthritis: A cytokine implicated in RA pathogenesis, IL-17, is often associated with chronic inflammatory conditions (6) and is also the target of monoclonal antibody (MAb) immunotherapy to treat inflammatory (including musculoskeletal) conditions (7).